Treatment Efficacy of Microsurgical Vasoepididymostomy for Obstructive Azoospermia: An Updated Systematic Review and Meta‐Analysis
Andrology · 2026
DOI: 10.1111/andr.70145 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Andrology, 2026. Verfasst von Jun Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Andrology Center, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Azoospermia, Epididymis, Microsurgery, Vas Deferens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Beijing Research-based Ward Excellence Program in Clinical Research: Establishing and Promoting Precision Diagnosis and Treatment System for Male Urogenital Di…, National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation.
Abstract (Originalsprache)
Background
Microsurgical vasoepididymostomy (MVE) is the standard treatment for epididymal obstructive azoospermia (EOA). However, existing studies report inconsistent pregnancy and patency rates.
Objectives
To comprehensively review the therapeutic effects of various MVE techniques on EOA, address prior research controversies, and identify factors influencing MVE efficacy. Materials and Methods Eligible studies focused on MVE outcomes, such as patency, pregnancy, or natural pregnancy rates. Relative pregnancy rate refers to natural pregnancies occurring in partners of patients with post‐operative patency. Meta‐analyses were performed using the “meta” R package. Heterogeneity was assessed with Q and I 2 tests.
Results
A total of 56 studies involving 3204 patients were included. End‐to‐end/end‐to‐side (EE/ES) techniques were associated with patency, pregnancy, and relative pregnancy rates of 65.0%, 23.0%, and 38.0%, respectively, whereas longitudinal intussusception vasoepididymostomy (LIVE) technique demonstrated slightly higher rates (68.0%, 27.0%, 40.0%). However these differences were not statistically significant (all p > 0.05). Compared with the 2‐suture TIVE (72.0%) and LIVE (58.0%; p < 0.01) techniques, the 3‐suture transverse intussusception vasoepididymostomy (TIVE) technique demonstrated significantly higher patency rates (89.0%). Pregnancy rates (33.0% vs. 26.0% vs. 28.0%) and relative pregnancy rates (38.0% vs. 33.0% vs. 42.0%) did not significantly differ among the three techniques ( p > 0.05). Single‐armed LIVE (SA‐LIVE) demonstrated numerically higher patency (69.0% vs. 64.0%), pregnancy (31.0% vs. 26.0%), and relative pregnancy rates (46.0% vs. 39.0%) compared with double‐armed LIVE (DA‐LIVE). However, these differences were not statistically significant (all p > 0.05). Vessel‐sparing SA‐LIVE demonstrated superior patency (83.0%) compared with classical SA‐LIVE (67.0%; p < 0.01), whereas pregnancy (38.0% vs. 31.0%) and relative pregnancy rates (both 47.0%) were not significantly different ( p > 0.05). Bilateral MVE, genital infections, and the presence of motile spermatozoa were associated with increased patency rates. The overall late failure rate was 23.0%, with significantly higher rates for the EE/ES techniques (32.0%) than the IVE technique (15.0%; p = 0.03).
Conclusion
This meta‐analysis confirms the efficacy of MVE for EOA. IVE has supplanted ES/EE, likely owing to its technical superiority and reduced rate of late failures, with LIVE emerging as the dominant approach. SA‐LIVE and DA‐LIVE yield comparable outcomes, and both should be recommended. Bilateral cases, infectious etiology, and motile epididymal spermatozoa predict increased patency rate. The relative pregnancy rate may better reflect effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Andrology Center, Peking University First Hospital, Beijing, China.
- Department of Urology, Peking University First Hospital, Beijing, China.
- Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
- Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
- Statistics Department, Peking University First Hospital, Beijing, China.
ORCID-Profile: Jing Peng
Förderung
- Beijing Research-based Ward Excellence Program in Clinical Research: Establishing and Promoting Precision Diagnosis and Treatment System for Male Urogenital Di…
- National Natural Science Foundation of China
- Beijing Municipal Natural Science Foundation
- the Interdisciplinary Research Project of Peking University First Hospital
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Zhu, J., Yang, Y., Zhu, S., Yuan, C., Tang, Y., Cui, W., Song, W., Yuan, Y., Jiang, H., Zhang, Z., & Peng, J. (2026). Treatment Efficacy of Microsurgical Vasoepididymostomy for Obstructive Azoospermia: An Updated Systematic Review and Meta‐Analysis. Andrology. https://doi.org/10.1111/andr.70145
Vancouver
Zhu J, Yang Y, Zhu S, Yuan C, Tang Y, Cui W, et al. Treatment Efficacy of Microsurgical Vasoepididymostomy for Obstructive Azoospermia: An Updated Systematic Review and Meta‐Analysis. Andrology. 2026. doi:10.1111/andr.70145
BibTeX
@article{Zhu2026,
author = {Zhu, Jun and Yang, Yuzhuo and Zhu, Sainan and Yuan, Changwei and Tang, Yuan and Cui, Wanshou and Song, Weidong and Yuan, Yiming and Jiang, Hui and Zhang, Zhichao and Peng, Jing},
title = {Treatment Efficacy of Microsurgical Vasoepididymostomy for Obstructive Azoospermia: An Updated Systematic Review and Meta‐Analysis},
journal = {Andrology},
year = {2026},
doi = {10.1111/andr.70145}
}
EUVIMED